Update on MR Imaging of cystic retroperitoneal masses

Kathleen Nguyen1, Evan S Siegelman2, Wendy Tu1

  • 1Department of Medical Imaging, The Ottawa Hospital, The University of Ottawa, Ottawa, Canada.

Abstract

Insights

This review covers magnetic resonance imaging (MRI) findings for cystic retroperitoneal (RP) masses. Lymphangiomas are common, but other diagnoses, including neoplasms, must be considered based on imaging characteristics.

Area of Science:

  • Radiology
  • Medical Imaging
  • Oncology

Background:

  • Cystic masses in the retroperitoneum (RP) can present diagnostic challenges.
  • Differentiating between various types of cystic RP masses is crucial for appropriate patient management.

Purpose of the Study:

  • To review the magnetic resonance imaging (MRI) appearance of cystic retroperitoneal masses.
  • To provide an approach for the MR imaging interpretation of these lesions.

Main Methods:

  • Review of literature and imaging findings of cystic retroperitoneal masses.
  • Analysis of imaging characteristics including location, internal complexity, and enhancement patterns.

Main Results:

  • Lymphangiomas are the most frequent cystic RP masses, often appearing simple on MRI.
  • Microscopic fat is a specific but insensitive indicator for lymphangiomas.
  • Location, internal features, and enhancement patterns are key to suggesting differential diagnoses.

Conclusions:

  • A systematic approach to MR imaging is essential for evaluating cystic retroperitoneal masses.
  • Differential diagnoses include normal variants, congenital abnormalities, and neoplasms (benign, neurogenic, malignant).

Related Concept Videos

Retroperitoneal Laparoscopic Debridement and Drainage for Pancreatic Abscess03:42

Retroperitoneal Laparoscopic Debridement and Drainage for Pancreatic Abscess

To improve the drainage of patients with necrotizing pancreatitis complicated with peripancreatic abscess and reduce the mortality of patients with necrotizing pancreatitis, we adopted a retroperitoneal approach for peripancreatic abscess debridement and drainage by...
1.1K
Rectal Organoid Morphology Analysis (ROMA): A Diagnostic Assay in Cystic Fibrosis07:56

Rectal Organoid Morphology Analysis (ROMA): A Diagnostic Assay in Cystic Fibrosis

This protocol describes rectal organoid morphology analysis (ROMA), a novel diagnostic assay for cystic fibrosis (CF). Morphological characteristics, namely the roundness (circularity index, CI) and the presence of a lumen (intensity ratio, IR), are a measure of CFTR function. Analysis of 189 subjects showed perfect discrimination between CF and...
3.2K
Investigation of Xenobiotics Metabolism In Salix alba Leaves via Mass Spectrometry Imaging09:21

Investigation of Xenobiotics Metabolism In Salix alba Leaves via Mass Spectrometry Imaging

This method uses mass spectrometry imaging (MSI) to understand metabolic processes in S. alba leaves when exposed to xenobiotics. The method allows the spatial localization of compounds of interest and their predicted metabolites within specific, intact...
3.5K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
735
Indocyanine Green-Guided Intraoperative Imaging to Facilitate Video-Assisted Retroperitoneal Debridement for Treating Acute Necrotizing Pancreatitis04:01

Indocyanine Green-Guided Intraoperative Imaging to Facilitate Video-Assisted Retroperitoneal Debridement for Treating Acute Necrotizing Pancreatitis

This protocol presents Indocyanine Green-guided video-assisted retroperitoneal debridement (ICG-guided VARD) for treating severe acute necrotizing...
2.9K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
479